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We welcome the opportunity to provide additional support for the assertion in our paper on 
sickle cell disease (SCD) in Africa that newborn screening can result in substantially 
reduced mortality even in the absence of specifıc interventions such as penicillin 
prophylaxis or pneumococcal conjugate vaccines (PCVs).1 Three references were cited 
describing reductions in SCD mortality that occurred prior to the availability of those 
interventions.2–4 In one U.S. study, the rate of mortality among infants with sickle cell 
anemia diagnosed as newborns in a pilot screening study during 1975–1985 was 1.8% 
compared with 8% among infants diagnosed after age 3 months, a difference attributed to 
better follow-up and education.2 The subsequent introduction of oral penicillin prophylaxis 
in the U.S. was associated with a 36% reduction in SCD mortality in children aged <4 years 
between 1983–1986 and 1987–1990.5 The administration of PCV-7 to U.S. infants 
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Newborn screening for SCD presents an important opportunity to reduce the burden of mortality in children aged <5 years in sub-
Saharan Africa.
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beginning in 2000, which eliminated many deaths from invasive pneumococcal disease 
(IPD) due to incomplete adherence to penicillin prophylaxis, was accompanied by a further 
42% drop in SCD mortality in children aged <4 years between 1995–1998 and 1999–2002.5
In Jamaica, King et al. and others documented sharp reductions in SCD mortality among 
infants born between 1973 and 1981 who were enrolled in the Jamaican Sickle Cell Cohort 
Study (JSCCS).4,6 The rate of death in the fırst 2 years of life fell by 71% from 14% in the 
1973–1975 birth cohort to 4% in the 1979–1981 birth cohort. One specific intervention, 
parental education on the detection of enlarged spleens and need for medical attention, was 
shown to result in a 74% decrease in the death rate from acute splenic sequestration (ASS) 
from 1.3 per 100 patient-years during 1974–1978 to 0.3 per 100 patient-years during 1979–
1983, calculated from data on incidence and case-fatality of ASS.4,7
Among the 1995–2006 birth cohort with SCD, the rate of death before age 2 years fell by a 
further 75%, to 1%, as a result of early-life interventions introduced after 1981.4 Chief 
among these is penicillin prophylaxis, which in Jamaica involves monthly intramuscular 
administration of long-acting penicillin with ~90% compliance.8 Although pneumococcal 
polysaccharide vaccine has been administered to children aged 4 years in Jamaica since 
1988, because of its cost few Jamaican children with SCD receive PCV.9 The Jamaican 
sickle cell disease program is highly effective and can serve as a model for resource-limited 
settings with good access to health care. One sentence in the current authors’ paper was 
interpreted to refer to contemporary SCD care in Jamaica, which was not the intent. King et 
al.4 was cited as an accessible source of information on the Jamaican historical 
experience.6,7 That experience demonstrates that newborn screening for SCD can result in 
dramatic improvements in child survival even if children are not provided with either 
penicillin prophylaxis or PCV, although both interventions are certainly important.
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